This analysis reveals the crystal structure and energy interactions of an iron(II) complex and its ligands, suggesting strong binding interactions.
The title compound, [Fe(C 18 H 11 N 6 O) 2 ]·2CH 3 OH, crystallizes in the orthorhombic space group Pbcn (No. 60) with half of the complex molecule and a methanol molecule in the asymmetric unit. In the complex, the two tridentate 3-(benzofuran-6-yl)-5-[6-(1 H -pyrazol-1-yl)pyridin-2-yl]-4 H -1,2,4-triazol ligands meridionally bind to the central Fe II ion through the N atoms of the heterocyclic groups, forming a pseudo-octahedral coordination sphere. In the crystal, C—H(pz)...π(ph) and C—H...N/C/O interactions consolidate the structure. Energy framework analysis at the B3LYP/6–31 G(d,p) theory level was performed to quantify the interaction energies in the crystal.
No takes yet. Share an insight, caveat, or question.
Terpeliuk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: